The Evaluation of Osmotic Pump as Glaucoma Drug Delivery System in Normal Dogs

被引:0
作者
Kim, Jury [1 ]
Kim, Min-Su [1 ]
机构
[1] Chonbuk Natl Univ, Coll Vet Med, Jeonju 561756, South Korea
关键词
Dog; Dorzolamide; Ocular delivery; Osmotic pump; Timolol; INTRAOCULAR-PRESSURE; RISK-FACTORS; FLUCTUATIONS; RELEASE;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The purpose of this study was to examine the effect of continuous release of an antiglaucomatous drug using osmotic pump compared with the effect of conventional eye drop. In group 1, one eye of each dog was treated with artificial tears. In group 2, the right eye was treated with a fixed combination of 2% dorzolamide and 0.5% timolol twice a day. In group 3, an osmotic pump filled with a fixed combination of 2% dorzolamide and 0.5% timolol was subcutaneously implanted over the left eye. In results the mean of intra ocular pressure (IOP) was 12.6 +/- 1.8 mmHg in group 3, 15.8 +/- 1.8 mmHg in group 2 and 17.3 +/- 1.0 mmHg in group 1, respectively. The osmotic pump presents a similar effect on IOP compared to conventional eye drop administration. From the study, it is known that the osmotic pump application can be used as the alternative method for the treatment of canine glaucoma. (C)2015 PVJ. All rights reserved
引用
收藏
页码:239 / 241
页数:3
相关论文
共 12 条
[1]  
Asrani S, 2000, J GLAUCOMA, V9, P134
[2]  
Blair MJ, 1999, AM J VET RES, V60, P1102
[3]   Electronic Monitoring to Assess Adherence With Once-Daily Glaucoma Medications and Risk Factors for Nonadherence The Automated Dosing Reminder Study [J].
Boland, Michael V. ;
Chang, Dolly S. ;
Frazier, Travis ;
Plyler, Ryan ;
Friedman, David S. .
JAMA OPHTHALMOLOGY, 2014, 132 (07) :838-844
[4]   Recent Perspectives in Ocular Drug Delivery [J].
Gaudana, Ripal ;
Jwala, J. ;
Boddu, Sai H. S. ;
Mitra, Ashim K. .
PHARMACEUTICAL RESEARCH, 2009, 26 (05) :1197-1216
[5]   In vitro-in vivo evaluation of nanosuspension release from subcutaneously implantable osmotic pumps [J].
Hill, A. ;
Geissler, S. ;
Meyring, M. ;
Hecht, S. ;
Weigandt, M. ;
Maeder, K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 451 (1-2) :57-66
[6]   Evaluation of risk factors for development of secondary glaucoma in dogs: 156 cases (1999-2004) [J].
Johnsen, Devin A. J. ;
Maggs, David J. ;
Kass, Philip H. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2006, 229 (08) :1270-1274
[7]   Biodegradable Implants for Sustained Drug Release in the Eye [J].
Lee, Susan S. ;
Hughes, Patrick ;
Ross, Aron D. ;
Robinson, Michael R. .
PHARMACEUTICAL RESEARCH, 2010, 27 (10) :2043-2053
[8]   Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs [J].
Plummer, Caryn E. ;
MacKay, Edward O. ;
Gelatt, Kirk N. .
VETERINARY OPHTHALMOLOGY, 2006, 9 (04) :245-249
[9]   AN OVERVIEW AND ADVANCEMENT IN OCULAR DRUG DELIVERY SYSTEMS [J].
Rathore, K. S. ;
Nema, R. K. ;
Sisodia, S. S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (10) :11-23
[10]  
Reinstein SL, 2009, COMPENDIUM, V31, P450